U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent subcortical infarcts

MedGen UID:
870472
Concept ID:
C4024918
Disease or Syndrome
HPO: HP:0007236

Term Hierarchy

Conditions with this feature

Orofaciodigital syndrome V
MedGen UID:
358131
Concept ID:
C1868118
Disease or Syndrome
Orofaciodigital syndrome V (OFD5) is an autosomal recessive disorder characterized by cleft palate/uvula, lobulated tongue, frontal bossing, hypertelorism, postaxial polydactyly, and impaired intellectual development (summary by Faily et al., 2017).
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
MedGen UID:
895965
Concept ID:
C4225211
Disease or Syndrome
HTRA1 disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) phenotype. Those who have a heterozygous HTRA1 pathogenic variant may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL. In this chapter, the term "classic CARASIL" refers to the more severe phenotype associated with biallelic pathogenic variants, and "HTRA1 cerebral small vessel disease" (HTRA1-CSVD) refers to the milder phenotype associated with a heterozygous HTRA1 pathogenic variant. Classic CARASIL is characterized by early-onset changes in the deep white matter of the brain observed on MRI, and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 40 years. Forty-four percent of affected individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly following the onset of neurologic symptoms. Scalp alopecia and acute mid- to lower-back pain (lumbago) before age 30 years are characteristic. The most frequent initial symptom in individuals with HTRA1-CSVD is slowly progressive gait disturbance after age 40 years, which may be followed by the development of mood changes and cognitive dysfunction. A majority of affected individuals have a stroke-like episode after age 40 years. Spondylosis and alopecia are seen in a minority of individuals with HTRA1-CSVD.
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
MedGen UID:
1634330
Concept ID:
C4551768
Disease or Syndrome
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is characterized by mid-adult onset of recurrent ischemic stroke, cognitive decline progressing to dementia, a history of migraine with aura, mood disturbance, apathy, and diffuse white matter lesions and subcortical infarcts on neuroimaging.

Professional guidelines

PubMed

Regenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A, Viswanathan A, Gurol ME, Chwalisz BK, Frosch MP, Cho TA, Greenberg SM
JAMA Neurol 2020 Oct 1;77(10):1261-1269. doi: 10.1001/jamaneurol.2020.1782. PMID: 32568365Free PMC Article
Mukai M, Mizuta I, Watanabe-Hosomi A, Koizumi T, Matsuura J, Hamano A, Tomimoto H, Mizuno T
J Hum Genet 2020 Aug;65(8):637-646. Epub 2020 Apr 10 doi: 10.1038/s10038-020-0751-9. PMID: 32277177
del Río-Espínola A, Mendióroz M, Domingues-Montanari S, Pozo-Rosich P, Solé E, Fernández-Morales J, Fernández-Cadenas I, Montaner J
Expert Rev Neurother 2009 Feb;9(2):197-210. doi: 10.1586/14737175.9.2.197. PMID: 19210195

Recent clinical studies

Etiology

Goldstein ED, Badi MK, Klaas JP, Glover P, Rozen TD, Huang JF, Lin MP, Meschia JF
Neurologist 2019 Nov;24(6):161-164. doi: 10.1097/NRL.0000000000000253. PMID: 31688705
Cumurciuc R, Henry P, Gobron C, Vicaut E, Bousser MG, Chabriat H, Vahedi K
Stroke 2006 Apr;37(4):1100-2. Epub 2006 Mar 2 doi: 10.1161/01.STR.0000209242.68844.20. PMID: 16514092

Diagnosis

Paraskevas GP, Bougea A, Synetou M, Vassilopoulou S, Anagnostou E, Voumvourakis K, Iliopoulos A, Spengos K
Cerebrovasc Dis 2014;38(4):302-7. Epub 2014 Nov 20 doi: 10.1159/000369000. PMID: 25412914
Cumurciuc R, Henry P, Gobron C, Vicaut E, Bousser MG, Chabriat H, Vahedi K
Stroke 2006 Apr;37(4):1100-2. Epub 2006 Mar 2 doi: 10.1161/01.STR.0000209242.68844.20. PMID: 16514092
Engelter ST, Rueegg S, Kirsch EC, Fluri F, Probst A, Steck AJ, Lyrer PA
Arch Neurol 2002 Sep;59(9):1480-3. doi: 10.1001/archneur.59.9.1480. PMID: 12223037

Clinical prediction guides

Goldstein ED, Badi MK, Klaas JP, Glover P, Rozen TD, Huang JF, Lin MP, Meschia JF
Neurologist 2019 Nov;24(6):161-164. doi: 10.1097/NRL.0000000000000253. PMID: 31688705
Engelter ST, Rueegg S, Kirsch EC, Fluri F, Probst A, Steck AJ, Lyrer PA
Arch Neurol 2002 Sep;59(9):1480-3. doi: 10.1001/archneur.59.9.1480. PMID: 12223037
Vérin M, Rolland Y, Landgraf F, Chabriat H, Bompais B, Michel A, Vahedi K, Martinet JP, Tournier-Lasserve E, Lemaitre MH
J Neurol Neurosurg Psychiatry 1995 Dec;59(6):579-85. doi: 10.1136/jnnp.59.6.579. PMID: 7500094Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...